放出制御型ドラッグデリバリー市場規模、シェア、動向分析レポート：技術別、放出メカニズム別、用途別、地域別、セグメント予測、2023年～2030年

放出制御型ドラッグデリバリー市場の成長と動向

GrandView Research, Inc.の最新レポートによると、世界の放出制御薬物デリバリー市場規模は、CAGR 10.6%を記録し、2030年までに1,101億3,000万米ドルに達すると予測されています。

治療効果の向上、副作用の軽減、治療コストの低減など、放出制御型ドラッグデリバリーシステムに関連する利点が、予測期間中の市場成長を促進する要因となっています。これらの技術は、従来の送達形態と比較して様々な利点を提供します。投与量と投与回数の削減、患者のコンプライアンス強化、胃腸への副作用の軽減、薬効の均一化、薬効と安全性の向上、血漿中薬物濃度の変動の軽減などは、放出制御技術が提供する主な利点の一部です。

薬物の吸収、バイオアベイラビリティ、安定性に影響を与える生体内の複数の生物学的障壁の存在は、放出制御型ドラッグデリバリー製品に広い地平を開いています。例えば、放出制御型ドラッグデリバリーシステムは、DNA/RNA、タンパク質、ポリペプチドなど、大きくて複雑な分子でさえもデリバリーすることを可能にしました。さらに、従来のシステムよりも放出制御型ドラッグ・デリバリー・システムの方が優れているという認識がヘルスケア専門家の間で高まっていることも、長期的には同市場の需要を押し上げると予想されます。

老年人口と小児人口の急増は、市場の成長に影響を与える主な要因の1つです。この年齢層では、処方箋の不着が大きな割合を占めているためです。様々なドラッグデリバリーシステムの革新は、老人や小児人口に簡単な解決策を提供しており、これが市場をさらに促進しています。薬物の放出制御は、特定の期間にわたって必要な投与量に応じて変化させることができるため、高齢者集団の過剰摂取を減らすことができます。

放出制御型ドラッグデリバリー市場レポートハイライト

• 用途別では、経口薬物放出制御システムが、使用量の増加と薬物投与の利便性により、2022年の市場シェアで最大を占めました。
• 標的ドラッグデリバリーは、治療効果の向上や安全性の向上など、さまざまな利点があることから、予測期間中に最も急成長する技術分野となる見込みです。
• 活性化調節ドラッグデリバリーシステムに基づく浸透圧デリバリー分野は、pH、食物摂取量、消化管運動などの様々な要因に影響されないため、CAGRが最も高くなると予想されます。

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
• 調査手法
• 情報調達
• 情報またはデータ分析
• 市場の形成と検証
• モデル詳細
• 二次情報のリスト
• 一次情報のリスト
• 目的

第2章 エグゼクティブサマリー

• 市場の見通し
• セグメントの見通し
• 競合考察

第3章 放出制御型ドラッグデリバリー市場変数、動向および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/アンシラリー市場見通し
• 普及と成長の見通しマッピング
• 業界のバリューチェーン分析
  • 償還の枠組み
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 放出制御型ドラッグデリバリー市場分析ツール
  • 業界分析- ポーターの分析
  • PESTEL分析
  • 主要取引と戦略的提携の分析
  • 市場参入戦略

第4章 世界の放出制御型ドラッグデリバリー市場：技術推定・動向分析

• 定義と範囲
• 放出制御型ドラッグデリバリー市場シェア、2022年および2030年
• セグメントダッシュボード
• 技術別：世界の放出制御型ドラッグデリバリー市場の展望
• 以下の市場規模、予測および傾向分析、2018年から2030年まで
  • ウルスターテクニック
  • コアセルベーション
  • マイクロカプセル化
  • インプラント
  • 経皮
  • ターゲットを絞った配信
  • その他（微小電気機械技術、リポソーム）

第5章 世界の放出制御型ドラッグデリバリー市場：放出メカニズムの推定・動向分析

• 定義と範囲
• 放出制御型ドラッグデリバリー市場シェア、2022年および2030年
• セグメントダッシュボード
• 放出メカニズム別：世界の放出制御型ドラッグデリバリー市場の見通し
• 以下の市場規模、予測および傾向分析、2018年から2030年まで
  • ポリマーベースのシステム
  • マイクロリザーバーパーティション制御ドラッグデリバリーシステム
  • フィードバック規制されたドラッグデリバリーシステム
  • 活性化調節ドラッグデリバリーシステム
  • 化学的に活性化された

第6章 世界の放出制御型ドラッグデリバリー市場：用途の推定・動向分析

• 定義と範囲
• 放出制御型ドラッグデリバリー市場シェア、2022年および2030年
• セグメントダッシュボード
• 用途別：世界の放出制御型ドラッグデリバリー市場の展望
• 以下の市場規模、予測および傾向分析、2018年から2030年まで
  • 定量吸入器
  • 注射可能
  • 経皮パッチおよび眼パッチ
  • 輸液ポンプ
  • 経口放出制御型ドラッグデリバリーシステム
  • 薬剤溶出ステント

第7章 世界の放出制御型ドラッグデリバリー市場：地域推定・動向分析

• 地域市場シェア分析、2022年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 地域市場シェアと主要企業、2022年
• SWOT分析、要因別（政治・法律、経済・技術）
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東とアフリカ
• 市場規模、予測、数量および動向分析、2018年から2030年：
• 北米
  • 市場推計・予測、2018～2030年
  • 米国
  • カナダ
• 欧州
  • 市場推計・予測、2018～2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ロシア
  • スイス
  • オランダ
  • スウェーデン
  • ベルギー
  • その他
• アジア太平洋地域
  • 市場推計・予測、2018～2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • タイ
  • インドネシア
  • フィリピン
  • ベトナム
  • マレーシア
  • シンガポール
  • その他
• ラテンアメリカ
  • 市場推計・予測、2018～2030年
  • ブラジル
  • メキシコ
  • アルゼンチン
  • コロンビア
  • チリ
  • その他
• MEA
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート
  • イスラエル
  • その他

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
• ベンダー情勢
• 公開会社
• 非公開会社
  • 主要な新興企業/テクノロジーディスラプター/イノベーターのリスト
  • 資金調達の見通し
  • 地域ネットワークマップ
  • 企業の市況分析（地理的プレゼンス、製品ポートフォリオ、主要な提携、業界経験）
  • サプライヤーランキング
  • 主要企業の概要
  • Depomed, Inc.
  • Coating Place, Inc.
  • Corium International, Inc.
  • Johnson and Johnson Services, Inc.
  • Alkermes plc
  • Pfizer, Inc.
  • Orbis Biosciences, Inc.
  • Capsugel
  • Merck and Co., Inc.
  • Aradigm Corporation

List of Tables

• Table 1 List of Abbreviation
• Table 2 North America controlled release drug delivery market, by region, 2018 - 2030 (USD Million)
• Table 3 North America controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 4 North America controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 5 North America controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 6 U.S. controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 7 U.S. controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 8 U.S. controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 9 Canada controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 10 Canada controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 11 Canada controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 12 Europe controlled release drug delivery market, by region, 2018 - 2030 (USD Million)
• Table 13 Europe controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 14 Europe controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 15 Europe controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 16 Germany controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 17 Germany controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 18 Germany controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 19 U.K. controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 20 U.K. controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 21 U.K. controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 22 France controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 23 France controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 24 France controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 25 Italy controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 26 Italy controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 27 Italy controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 28 Spain controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 29 Spain controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 30 Spain controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 31 The Netherland controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 32 The Netherland controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 33 The Netherland controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 34 Switzerland controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 35 Switzerland controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 36 Switzerland controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 37 Russia controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 38 Russia controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 39 Russia controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 40 Sweden controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 41 Sweden controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 42 Sweden controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 43 Belgium controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 44 Belgium controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 45 Belgium controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific controlled release drug delivery market, by region, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 50 Japan controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 51 Japan controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 52 Japan controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 53 China controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 54 China controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 55 China controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 56 India controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 57 India controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 58 India controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 59 South Korea controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 60 South Korea controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 61 South Korea controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 62 Thailand controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 63 Thailand controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 64 Thailand controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 65 Indonesia controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 66 Indonesia controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 67 Indonesia controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 68 Philippines controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 69 Philippines controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 70 Philippines controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 71 Vietnam controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 72 Vietnam controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 73 Vietnam controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 74 Singapore controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 75 Singapore controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 76 Singapore controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 77 Malaysia controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 78 Malaysia controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 79 Malaysia controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 80 Latin America controlled release drug delivery market, by region, 2018 - 2030 (USD Million)
• Table 81 Latin America controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 82 Latin America controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 83 Latin America controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 84 Brazil controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 85 Brazil controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 86 Brazil controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 87 Mexico controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 88 Mexico controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 89 Mexico controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 90 Argentina controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 91 Argentina controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 92 Argentina controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 93 Colombia controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 94 Colombia controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 95 Colombia controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 96 Chile controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 97 Chile controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 98 Chile controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 99 Middle east and Africa controlled release drug delivery market, by region, 2018 - 2030 (USD Million)
• Table 100 Middle east and Africa controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 101 Middle east and Africa controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 102 Middle east and Africa controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 103 South Africa controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 104 South Africa controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 105 South Africa controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 106 Saudi Arabia controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 109 UAE controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 110 UAE controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 111 UAE controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 112 Kuwait controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 113 Kuwait controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 114 Kuwait controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
• Table 115 Israel controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
• Table 116 Israel controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
• Table 117 Israel controlled release drug delivery market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 controlled release drug delivery market: market outlook
• Fig. 14 controlled release drug delivery market competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 controlled release drug delivery market driver impact
• Fig. 20 controlled release drug delivery market restraint impact
• Fig. 21 controlled release drug delivery market strategic initiatives analysis
• Fig. 22 controlled release drug delivery market: technology movement analysis
• Fig. 23 controlled release drug delivery market: technology outlook and key takeaways
• Fig. 24 Wurster technique market estimates and forecast, 2018 - 2030
• Fig. 25 Coacervation market estimates and forecast, 2018 - 2030
• Fig. 26 Micro encapsulation market estimates and forecast, 2018 - 2030
• Fig. 27 Implants market estimates and forecast, 2018 - 2030
• Fig. 28 Transdermal market estimates and forecast, 2018 - 2030
• Fig. 29 Targeted delivery market estimates and forecast, 2018 - 2030
• Fig. 30 Others market estimates and forecast, 2018 - 2030
• Fig. 31 controlled release drug delivery market: release mechanism movement analysis
• Fig. 32 controlled release drug delivery market: release mechanism outlook and key takeaways
• Fig. 33 Polymer based systems market estimates and forecast, 2018 - 2030
• Fig. 34 Micro reservoir partition-controlled drug delivery systems estimate and forecasts, 2018 - 2030
• Fig. 35 Feedback regulate drug delivery systems estimates and forecasts, 2018 - 2030
• Fig. 36 Activation-modulated drug delivery systems estimates and forecasts, 2018 - 2030
• Fig. 37 Chemically activated drug delivery systems estimates and forecasts, 2018 - 2030
• Fig. 38 controlled release drug delivery market: application movement analysis
• Fig. 39 controlled release drug delivery market: application outlook and key takeaways
• Fig. 40 Metered dose inhaler market estimates and forecasts, 2018 - 2030
• Fig. 41 Injectable controlled release drug delivery market estimates and forecasts, 2018 - 2030
• Fig. 42 Transdermal and Ocular patches controlled release drug delivery market estimates and forecasts, 2018 - 2030
• Fig. 43 Infusion pumps controlled release drug delivery market estimates and forecasts, 2018 - 2030
• Fig. 44 Oral controlled drug delivery systems market estimates and forecasts, 2018 - 2030
• Fig. 45 Drug eluting stents controlled release drug delivery market estimates and forecasts, 2018 - 2030
• Fig. 46 Global controlled release drug delivery market: regional movement analysis
• Fig. 47 Global controlled release drug delivery market: regional outlook and key takeaways
• Fig. 48 Global controlled release drug delivery market shares and leading players
• Fig. 49 North America market share and leading players
• Fig. 50 Europe market share and leading players
• Fig. 51 Asia Pacific market share and leading players
• Fig. 52 Latin America market share and leading players
• Fig. 53 Middle East & Africa market share and leading players
• Fig. 54 North America: SWOT
• Fig. 55 Europe SWOT
• Fig. 56 Asia Pacific SWOT
• Fig. 57 Latin America SWOT
• Fig. 58 MEA SWOT
• Fig. 59 North America, by country
• Fig. 60 North America
• Fig. 61 North America market estimates and forecasts, 2018 - 2030
• Fig. 62 U.S.
• Fig. 63 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 64 Canada
• Fig. 65 Canada market estimates and forecasts, 2018 - 2030
• Fig. 66 Europe
• Fig. 67 Europe. market estimates and forecasts, 2018 - 2030
• Fig. 68 UK
• Fig. 69 UK market estimates and forecasts, 2018 - 2030
• Fig. 70 Germany
• Fig. 71 Germany market estimates and forecasts, 2018 - 2030
• Fig. 72 France
• Fig. 73 France market estimates and forecasts, 2018 - 2030
• Fig. 74 Italy
• Fig. 75 Italy market estimates and forecasts, 2018 - 2030
• Fig. 76 Spain
• Fig. 77 Spain market estimates and forecasts, 2018 - 2030
• Fig. 78 Russia
• Fig. 79 Russia market estimates and forecasts, 2018 - 2030
• Fig. 80 The Netherlands
• Fig. 81 The Netherlands market estimates and forecasts, 2018 - 2030
• Fig. 82 Switzerland
• Fig. 83 Switzerland market estimates and forecasts, 2018 - 2030
• Fig. 84 Sweden
• Fig. 85 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 86 Belgium
• Fig. 87 Belgium market estimates and forecasts, 2018 - 2030
• Fig. 88 Asia Pacific
• Fig. 89 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 90 China
• Fig. 91 China market estimates and forecasts, 2018 - 2030
• Fig. 92 Japan
• Fig. 93 Japan market estimates and forecasts, 2018 - 2030
• Fig. 94 India
• Fig. 95 India market estimates and forecasts, 2018 - 2030
• Fig. 96 Thailand
• Fig. 97 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 98 South Korea
• Fig. 99 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 100 Indonesia
• Fig. 101 Indonesia market estimates and forecasts, 2018 - 2030
• Fig. 102 Philippines
• Fig. 103 Taiwan market estimates and forecasts, 2018 - 2030
• Fig. 104 Vietnam
• Fig. 105 Singapore market estimates and forecasts, 2018 - 2030
• Fig. 106 Singapore
• Fig. 107 Australia market estimates and forecasts, 2018 - 2030
• Fig. 108 Malaysia
• Fig. 109 Malaysia market estimates and forecasts, 2018 - 2030
• Fig. 110 Latin America
• Fig. 111 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 112 Brazil
• Fig. 113 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 114 Mexico
• Fig. 115 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 116 Argentina
• Fig. 117 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 118 Colombia
• Fig. 119 Colombia market estimates and forecasts, 2018 - 2030
• Fig. 120 Chile
• Fig. 121 Chile market estimates and forecasts, 2018 - 2030
• Fig. 122 Middle East and Africa
• Fig. 123 Middle East and Africa. market estimates and forecasts, 2018 - 2030
• Fig. 124 South Africa
• Fig. 125 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 126 Saudi Arabia
• Fig. 127 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 128 UAE
• Fig. 129 UAE market estimates and forecasts, 2018 - 2030
• Fig. 130 Kuwait
• Fig. 131 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 132 Israel
• Fig. 133 Israel market estimates and forecasts, 2018 - 2030
• Fig. 134 Participant categorization- controlled release drug delivery market
• Fig. 135 Market share of key market players- controlled release drug delivery market

Controlled Release Drug Delivery Market Growth & Trends

The global controlled release drug delivery market size is expected to reach USD 110.13 billion by 2030, registering a CAGR of 10.6% according to a new report by Grand View Research, Inc. The benefits associated with controlled release drug delivery systems such as increased therapeutic efficacy, fewer side effects, and low treatment cost are the factors driving the growth of the market during the forecast period. These technologies offer various benefits over traditional delivery forms. Reduced dosage and dosage frequency, enhanced patient compliance, less gastrointestinal side effects, uniform drug effect, improved drug efficacy and safety, and reduced fluctuation of plasma drug levels are some of the major advantages offered by controlled release technology.

The presence of multiple in-vivo biological barriers that affect the absorption, bioavailability, and stability of the drug has opened a wide horizon for controlled release drug delivery products. For instance, a controlled release drug delivery system has enabled the delivery of even large and complex molecules such as DNA/RNA, proteins, and polypeptides. Additionally, the rising awareness among healthcare professionals, regarding the advantage of controlled release drug delivery systems over conventional systems is expected to drive the demand for the market in long run.

The rapidly increasing geriatric and pediatric population is one of the major factors impacting the growth of the market. Since a major proportion of prescription non-adherence cases is observed in this age group of the population. Innovations in various drug delivery systems have been providing the geriatric and pediatric populations with easy solutions, which are further propelling the market. Controlled release of drugs allows a reduction in overdose in the elderly population as they can be altered according to the required dosage over a specific period of time.

Controlled Release Drug Delivery Market Report Highlights

• Based on application, oral controlled release systems held the largest share in the market in 2022 owing to increasing usage and ease of convenience offered for the administration of medication
• Targeted drug delivery is poised to be the fastest-growing technology segment during the forecast period owing to its various benefits such as increased therapeutic efficacy coupled with increased safety
• The osmotic delivery segment, based on activation modulation drug delivery systems, is likely to witness the highest CAGR due to its ability to not be affected by various factors, such as pH, food consumption, and gastrointestinal motility

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Technology
  • 1.1.2. Release mechanism
  • 1.1.3. Application
  • 1.1.4. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Technology outlook
  • 2.2.2. Release mechanism outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. controlled release drug delivery Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. Increase in need for controlled release dosage forms for pediatric and geriatric population
    • 3.4.1.2. Increased compliance due to nature of dosage forms
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. Limited amount of controlled release dosage forms is acceptable for usage in pediatric conditions
    • 3.4.2.2. Need for high dose of active pharmaceutical ingredient
• 3.5. controlled release drug delivery Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
  • 3.5.3. Major Deals & Strategic Alliances Analysis
  • 3.5.4. Market Entry Strategies

Chapter 4. Global controlled release drug delivery Market: Technology Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Wurster technique
  • 4.1.2. Coacervation
  • 4.1.3. Micro encapsulation
  • 4.1.4. Implants
  • 4.1.5. Transdermal
  • 4.1.6. Targeted delivery
  • 4.1.7. Others (microelectromechanical technology, liposomes)
• 4.2. Controlled release drug delivery Market Share, 2022 & 2030
• 4.3. Segment Dashboard
• 4.4. Global controlled release drug delivery Market by Technology Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. Wurster technique
    • 4.5.1.1. Wurster technique controlled release drug delivery market, 2018 - 2030 (USD Million)
  • 4.5.2. Coacervation
    • 4.5.2.1. Coacervation controlled release drug delivery market, 2018 - 2030 (USD Million)
  • 4.5.3. Micro Encapsulation
    • 4.5.3.1. Micro encapsulation controlled release drug delivery market, 2018 - 2030 (USD Million)
  • 4.5.4. Implants
    • 4.5.4.1. Implants controlled release drug delivery market, 2018 - 2030 (USD Million)
  • 4.5.5. Transdermal
    • 4.5.5.1. Transdermal controlled release drug delivery market, 2018 - 2030 (USD Million)
  • 4.5.6. Targeted delivery
    • 4.5.6.1. Targeted delivery controlled release drug delivery market, 2018 - 2030 (USD Million)
  • 4.5.7. Others (microelectromechanical technology, liposomes)
    • 4.5.7.1. Others controlled release drug delivery market, 2018 - 2030 (USD Million)

Chapter 5. Global controlled release drug delivery Market: Release Mechanism Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Polymer Based Systems
  • 5.1.2. Micro Reservoir Partition Controlled Drug Delivery Systems
  • 5.1.3. Feedback Regulated Drug Delivery Systems
  • 5.1.4. Activation-modulated Drug Delivery Systems
    • 5.1.4.1. Osmotic Pressure Activated
    • 5.1.4.2. Hydrodynamic Pressure Activated
    • 5.1.4.3. Vapor Pressure Activated
    • 5.1.4.4. Mechanically Activated
    • 5.1.4.5. Magnetically Activated
  • 5.1.5. Chemically Activated
    • 5.1.5.1. pH Activated
    • 5.1.5.2. Hydrolysis Activated
    • 5.1.5.3. Enzyme Activated
• 5.2. Controlled release drug delivery Market Share, 2022 & 2030
• 5.3. Segment Dashboard
• 5.4. Global controlled release drug delivery Market by Release Mechanism Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Polymer based systems
    • 5.5.1.1. Polymer based systems controlled release drug delivery market, 2018 - 2030 (USD Million)
  • 5.5.2. Micro reservoir partition controlled drug delivery systems
    • 5.5.2.1. Micro reservoir partition controlled drug delivery systems market, 2018 - 2030 (USD Million)
  • 5.5.3. Feedback regulated drug delivery systems
    • 5.5.3.1. Feedback regulated drug delivery systems market, 2018 - 2030 (USD Million)
  • 5.5.4. Activation-modulated drug delivery systems
    • 5.5.4.1. Activation-modulated drug delivery systems market, 2018 - 2030 (USD Million)
    • 5.5.4.2. Osmotic pressure activated systems market, 2018 - 2030 (USD Million)
    • 5.5.4.3. Hydrodynamic pressure activated systems market, 2018 - 2030 (USD Million)
    • 5.5.4.4. Vapor pressure activated systems market, 2018 - 2030 (USD Million)
    • 5.5.4.5. Mechanically activated systems market, 2018 - 2030 (USD Million)
    • 5.5.4.6. Magnetically activated systems market, 2018 - 2030 (USD Million)
  • 5.5.5. Chemically activated
    • 5.5.5.1. pH activated controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 5.5.5.2. Hydrolysis activated controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 5.5.5.3. Enzyme activated controlled release drug delivery market, 2018 - 2030 (USD Million)

Chapter 6. Global controlled release drug delivery Market: Application Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Metered Dose Inhalers
  • 6.1.2. Injectable
  • 6.1.3. Transdermal and Ocular Patches
  • 6.1.4. Infusion Pumps
  • 6.1.5. Oral Controlled-drug delivery Systems
  • 6.1.6. Drug Eluting Stents
• 6.2. controlled release drug delivery Market Share, 2022 & 2030
• 6.3. Segment Dashboard
• 6.4. Global controlled release drug delivery Market by Application Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Metered dose inhalers
    • 6.5.1.1. Metered dose inhaler controlled release drug delivery market, 2018 - 2030 (USD Million)
  • 6.5.2. Injectable
    • 6.5.2.1. Injectable controlled release drug delivery market, 2018 - 2030 (USD Million)
  • 6.5.3. Transdermal and ocular patches
    • 6.5.3.1. Transdermal and ocular patches controlled release drug delivery market, 2018 - 2030 (USD Million)
  • 6.5.4. Infusion Pumps
    • 6.5.4.1. Infusion pumps controlled release drug delivery market, 2018 - 2030 (USD Million)
  • 6.5.5. Oral controlled release drug delivery system
    • 6.5.5.1. Oral controlled release drug delivery market, 2018 - 2030 (USD Million)
  • 6.5.6. Drug eluting stents
    • 6.5.6.1. Drug eluting stents controlled release drug delivery market, 2018 - 2030 (USD Million)

Chapter 7. Global controlled release drug delivery Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2022 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Regional Market Share and Leading Players, 2022
  • 7.4.1. North America
  • 7.4.2. Europe
  • 7.4.3. Asia Pacific
  • 7.4.4. Latin America
  • 7.4.5. Middle East and Africa
• 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
  • 7.5.1. North America
  • 7.5.2. Europe
  • 7.5.3. Asia Pacific
  • 7.5.4. Latin America
  • 7.5.5. Middle East and Africa
• 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
• 7.7. North America
  • 7.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.2. U.S.
    • 7.7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.3. Canada
    • 7.7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 7.8. Europe
  • 7.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.2. UK
    • 7.8.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.3. Germany
    • 7.8.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.4. France
    • 7.8.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.5. Italy
    • 7.8.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.6. Spain
    • 7.8.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.7. Russia
    • 7.8.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.8. Switzerland
    • 7.8.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.9. The Netherland
    • 7.8.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.10. Sweden
    • 7.8.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.11. Belgium
    • 7.8.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.12. Others
    • 7.8.12.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 7.9. Asia Pacific
  • 7.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.2. Japan
    • 7.9.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.3. China
    • 7.9.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.4. India
    • 7.9.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.5. South Korea
    • 7.9.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.6. Thailand
    • 7.9.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.7. Indonesia
    • 7.9.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.8. Philippines
    • 7.9.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.9. Vietnam
    • 7.9.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.10. Malaysia
    • 7.9.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.11. Singapore
    • 7.9.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.12. Others
    • 7.9.12.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 7.10. Latin America
  • 7.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.10.2. Brazil
    • 7.10.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.10.3. Mexico
    • 7.10.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.10.4. Argentina
    • 7.10.4.7. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.10.5. Colombia
    • 7.10.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.10.6. Chile
    • 7.10.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.10.7. Others
    • 7.10.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
• 7.11. MEA
  • 7.11.1. South Africa
    • 7.11.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.11.2. Saudi Arabia
    • 7.11.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.11.3. UAE
    • 7.11.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.11.4. Kuwait
    • 7.11.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.11.5. Israel
    • 7.11.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.11.6. Others
    • 7.11.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
  • 8.2.2. Market Leaders
  • 8.2.3. Emerging Players
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2022
• 8.4. Public Companies
  • 8.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
  • 8.4.2. Company market share/ranking, by region
  • 8.4.3. Competitive dashboard analysis
    • 8.4.3.1. Market differentiators
    • 8.4.3.2. Synergy analysis: major deals and strategic alliances
• 8.5. Private Companies
  • 8.5.1. List of key emerging company's/technology disruptors/innovators
  • 8.5.2. Funding outlook
  • 8.5.3. Regional network map
  • 8.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
  • 8.5.5. Supplier ranking
  • 8.5.6. Key company profiled
  • 8.5.7. Depomed, Inc.
    • 8.5.7.1. Company overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Coating Place, Inc.
    • 8.5.8.1. Company overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Corium International, Inc.
    • 8.5.9.1. Company overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Johnson and Johnson Services, Inc.
    • 8.5.10.1. Company overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product benchmarking
    • 8.5.10.4. Strategic Initiative
  • 8.5.11. Alkermes plc
    • 8.5.11.1. Company overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product benchmarking
    • 8.5.11.4. Strategic initiatives
  • 8.5.12. Pfizer, Inc.
    • 8.5.12.1. Company overview
    • 8.5.12.2. Financial performance
    • 8.5.12.3. Product benchmarking
    • 8.5.12.4. Strategic initiatives
  • 8.5.13. Orbis Biosciences, Inc.
    • 8.5.13.1. Company overview
    • 8.5.13.2. Financial performance
    • 8.5.13.3. Product benchmarking
    • 8.5.13.4. Strategic initiatives
  • 8.5.14. Capsugel
    • 8.5.14.1. Company overview
    • 8.5.14.2. Financial performance
    • 8.5.14.3. Product benchmarking
    • 8.5.14.4. Strategic initiatives
  • 8.5.15. Merck and Co., Inc.
    • 8.5.15.1. Company overview
    • 8.5.15.2. Financial performance
    • 8.5.15.3. Product benchmarking
    • 8.5.15.4. Strategic initiatives
  • 8.5.16. Aradigm Corporation
    • 8.5.16.1. Company overview
    • 8.5.16.2. Financial performance
    • 8.5.16.3. Product benchmarking
    • 8.5.16.4. Strategic initiatives